Printer Friendly Version  PrintE-mail this page  E-mailRSS RSS FeedsE-mail Alerts E-mail Alerts
IR Home
Corporate Profile
Founded in December 2000 and based in Shanghai, WuXi (pronounced Woo-See) PharmaTech is the leading China-based pharmaceutical and biotechnology R&D outsourcing company. As a research-driven and customer-focused company, WuXi PharmaTech offers global pharmaceutical and biotechnology companies a broad and integrated portfolio of laboratory and research manufacturing services ranging from discovery chemistry to biological services and manufacturing of APIs for R&D use. More >>
What's New
download pdf  Corporate Factsheet
Stock Quote
WX (Common Stock)
ExchangeNYSE (US Dollar)
Price$20.29
Change (%) Stock is Down 0.71 (3.38%)
Volume192,446
Data as of 07/24/08 1:35 p.m. ET
Minimum 20 minute delay
Refresh quote
Interactive Calendar
July 2008?
Calendar Help
This calendar contains six months of past and future company related information, which may include press releases, SEC filings, calendar events and more. Dates containing information are indicated by a colored background. Please select a highlighted date from the calendar to see date-specific company information, including a link to additional information. This calendar requires JavaScript to be installed and activated on your browser.
Calendar Icon Legend:
Analyst Meeting
Conference
Conference Presentation
Corporate Conference Call
Custom Events
Earnings Conference Call
Earnings Release
Financial Reports
Mergers & Acquisition Announcement
Guidance Announcement
Other Corporate
Sales Call/Presentation
Sales Release
Shareholders Meeting
News Release
SEC Filings
Presentations
52 Week High
Today
SunMonTueWedThuFriSat
-2-112345
6789101112
13141516171819
20212223242526
27282930315152
Calendar Instructions
Please select a highlighted date from the calendar to view company related information. This calendar requires JavaScript to be installed and activated on your browser.
Recent NewsMore >>
DateTitle 
07/14/08Warburg Pincus Acquires 5.4% of WuXi PharmaTech's Outstanding Ordinary Shares from United Overseas Bank
SHANGHAI, China, July 14 /Xinhua-PRNewswire/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today announced that Warburg Pincus, the global private equity firm, has acquired 5.4% of its outstanding ordinary shares from affiliates of United Overseas Bank. At the closing of the transaction on July 2, 2008, affiliates of United Overseas Bank (UOB),... 
Printer Friendly Version
07/14/08Dr. Richard M. Soll Joined WuXi PharmaTech (NYSE: WX) as VP of Medicinal Chemistry
SHANGHAI, China, July 14, 2008 /Xinhua-PRNewswire via COMTEX News Network/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, announced today that Dr. Richard M. Soll has joined WuXi PharmaTech as Vice President of Medicinal Chemistry. As a pharmaceutical veteran, Dr. Soll brings over 25 years of scientific experience and proven leadership capability to his ... 
Printer Friendly Version
07/11/08WuXi PharmaTech (NYSE: WX) Wins the 2008 Frost & Sullivan Award for Best in Class Outsourced R&D in Pharmaceuticals and Biotechnology
SHANGHAI, China, July 11 /Xinhua-PRNewswire/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today proudly announced that it has won the 2008 Frost & Sullivan Award for Best in Class Outsourced R&D in Pharmaceuticals and Biotechnology. Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demons... 
Printer Friendly Version
07/10/08WuXi PharmaTech (NYSE: WX) Named the Most Innovative Company in China and CEO Dr. Li the Most Innovative Leader of Chinese Enterprises
SHANGHAI, China, July 10 /Xinhua-PRNewswire/ -- WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today announced that it was awarded one of the top 20 "China Most Innovative Enterprises" and its CEO Dr. Ge Li was named one of the top 10 "Most Innovative Leaders of Chinese Enterprises" at the 8th China Enterprise Innovation Forum held in Beijing last month. ... 
Printer Friendly Version
Upcoming EventsMore >>
There are currently no events scheduled.
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever WuXi PharmaTech Co., Ltd. posts new information to the site. Just enter your e-mail address and click Submit.
 

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.



Copyright © 2008 WuXi PharmaTech Co., Ltd. All rights reserved.